Beijing, China

Email:

customer@cnphds.com

Phone:

+86-10-84466227

+86-10-84466228

+86-10-84466229

View Offices Request a Proposal
Before

PHDS has finalized the modification of the drug supplementary application

Published:2006-10-01

According to file No. 24 of SFDA, PHDS has finalized the modification of drug package, label and instruction, and the improvement of the specifications for Axetine (Cefuroxime Sodium for Injection) and Medocef (Cefoperazone Sodium for Injection), manufactured in Cyprus.